New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis

Background: Chondrosarcoma responds poorly to adjuvant therapy and new, clinically relevant animal models are required to test targeted therapy. Methods: Two human chondrosarcoma cell lines, JJ012 and FS090, were evaluated for proliferation, colony formation, invasion, angiogenesis and osteoclastoge...

Full description

Bibliographic Details
Main Authors: Clark, J., Akiyama, T., Dass, Crispin, Choong, P.
Format: Journal Article
Published: BioMed Central Ltd 2010
Online Access:http://hdl.handle.net/20.500.11937/18021
_version_ 1848749625451741184
author Clark, J.
Akiyama, T.
Dass, Crispin
Choong, P.
author_facet Clark, J.
Akiyama, T.
Dass, Crispin
Choong, P.
author_sort Clark, J.
building Curtin Institutional Repository
collection Online Access
description Background: Chondrosarcoma responds poorly to adjuvant therapy and new, clinically relevant animal models are required to test targeted therapy. Methods: Two human chondrosarcoma cell lines, JJ012 and FS090, were evaluated for proliferation, colony formation, invasion, angiogenesis and osteoclastogenesis. Cell lines were also investigated for VEGF, MMP-2, MMP-9, and RECK expression. JJ012 and FS090 were injected separately into the mouse tibia intramedullary canal or tibial periosteum. Animal limbs were measured, and x-rayed for evidence of tumour take and progression. Tibias and lungs were harvested to determine the presence of tumour and lung metastases. Results: JJ012 demonstrated significantly higher proliferative capacity, invasion, and colony formation in collagen I gel. JJ012 conditioned medium stimulated endothelial tube formation and osteoclastogenesis with a greater potency than FS090 conditioned medium, perhaps related to the effects of VEGF and MMP-9. In vivo, tumours formed in intratibial and periosteal groups injected with JJ012, however no mice injected with FS090 developed tumours. JJ012 periosteal tumours grew to 3 times the non-injected limb size by 7 weeks, whereas intratibial injected limbs required 10 weeks to achieve a similar tumour size. Sectioned tumour tissue demonstrated features of grade III chondrosarcoma. All JJ012 periosteal tumours (5/5) resulted in lung micro-metastases, while only 2/4 JJ012 intratibial tumours demonstrated metastases. Conclusions: The established JJ012 models replicate the site, morphology, and many behavioural characteristics of human chondrosarcoma. Local tumour invasion of bone and spontaneous lung metastasis offer valuable assessment tools to test the potential of novel agents for future chondrosarcoma therapy.
first_indexed 2025-11-14T07:23:55Z
format Journal Article
id curtin-20.500.11937-18021
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:23:55Z
publishDate 2010
publisher BioMed Central Ltd
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-180212017-09-13T15:44:54Z New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis Clark, J. Akiyama, T. Dass, Crispin Choong, P. Background: Chondrosarcoma responds poorly to adjuvant therapy and new, clinically relevant animal models are required to test targeted therapy. Methods: Two human chondrosarcoma cell lines, JJ012 and FS090, were evaluated for proliferation, colony formation, invasion, angiogenesis and osteoclastogenesis. Cell lines were also investigated for VEGF, MMP-2, MMP-9, and RECK expression. JJ012 and FS090 were injected separately into the mouse tibia intramedullary canal or tibial periosteum. Animal limbs were measured, and x-rayed for evidence of tumour take and progression. Tibias and lungs were harvested to determine the presence of tumour and lung metastases. Results: JJ012 demonstrated significantly higher proliferative capacity, invasion, and colony formation in collagen I gel. JJ012 conditioned medium stimulated endothelial tube formation and osteoclastogenesis with a greater potency than FS090 conditioned medium, perhaps related to the effects of VEGF and MMP-9. In vivo, tumours formed in intratibial and periosteal groups injected with JJ012, however no mice injected with FS090 developed tumours. JJ012 periosteal tumours grew to 3 times the non-injected limb size by 7 weeks, whereas intratibial injected limbs required 10 weeks to achieve a similar tumour size. Sectioned tumour tissue demonstrated features of grade III chondrosarcoma. All JJ012 periosteal tumours (5/5) resulted in lung micro-metastases, while only 2/4 JJ012 intratibial tumours demonstrated metastases. Conclusions: The established JJ012 models replicate the site, morphology, and many behavioural characteristics of human chondrosarcoma. Local tumour invasion of bone and spontaneous lung metastasis offer valuable assessment tools to test the potential of novel agents for future chondrosarcoma therapy. 2010 Journal Article http://hdl.handle.net/20.500.11937/18021 10.1186/1475-2867-10-20 BioMed Central Ltd unknown
spellingShingle Clark, J.
Akiyama, T.
Dass, Crispin
Choong, P.
New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
title New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
title_full New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
title_fullStr New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
title_full_unstemmed New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
title_short New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
title_sort new clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
url http://hdl.handle.net/20.500.11937/18021